Effects of vehicle and VIP (1, 10 and 100 pmol) microinjected into the nAmb on intragastric PRIGP and PCA and GCCA as well as on MAP in five animals1-a
| Treatment | PRIGP | PCA | GCCA | MAP |
|---|---|---|---|---|
| cm H2O | MMI | mm Hg | ||
| Vehicle | 0.4 ± 0.2 | 0.5 ± 0.8 | 0.1 ± 0.4 | 0 ± 0 |
| VIP (1 pmol) | 0.6 ± 0.4 | −1.8 ± 1.3 | −0.1 ± 0.2 | −2.0 ± 1.2 |
| VIP (10 pmol) | 0.6 ± 0.1 | −0.8 ± 1.2 | 0.5 ± 0.4 | 0 ± 1.6 |
| VIP (100 pmol) | 0.6 ± 0.1 | 0.6 ± 1.0 | −0.2 ± 0.6 | 1 ± 1 |
↵1-a Values are means ± S.E. Abbreviations: PRIGP, pressure peak response; PCA, pyloric circular muscle contractile activity; GCCA, greater curvature longitudinal muscle contractile activity.